Related Experiment Video
Updated: Jul 3, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
3DICE: interpretable 3D cross-modal learning for drug-target interaction prediction and large-scale drug discovery
Austin Zi Rui Liu1,2, Nguyen Quoc Khanh Le2,3,4, Matthew Chin Heng Chua5
1Raffles Institution, Singapore, 575954, Singapore.
Motivation:
Drug-target interaction (DTI) prediction is a crucial step in modern drug discovery. Accurate and efficient predictions can substantially reduce costs and development time. Applications of deep learning methods for this purpose have been extensively studied in recent years, yielding instrumental contributions to this field. However, existing methods face issues pertaining to efficient learning of drug and target feature representations, which is detrimental to generalizability and performance in cold-start scenarios. Most approaches extract representations from SMILES strings for drugs and FASTA sequences for target proteins, which encode limited 3D structural information. Additionally, many models lack explainability, being black boxes that provide little physical insight into the underlying mechanisms behind such interactions.
Results:
We propose 3DICE, a novel framework leveraging co-attention-based fusion and massively pre-trained 3D structural encoders for both drugs and proteins. Uni-Mol and ESM-IF1 are employed to generate high-fidelity, 3D structure-aware embeddings which enable richer geometric and chemical understanding. Cross-modal fusion modules further augment representations to model intermolecular binding relationships. Importantly, this mechanism also provides intrinsic interpretability, highlighting and enabling qualitative analysis of most influential atoms or residues. Experiments conducted on two canonical benchmark datasets display the competitiveness of our model in real-world scenarios. 3DICE outperformed state-of-the-art models across multiple metrics on the DrugBank and KIBA datasets. Additional experiments provide a more rigorous analysis of interpretability than is typically reported in prior DTI studies, and we find that attention consistently highlights decision-critical regions which is not intrinsically class-specific.
Availability:
Our model and dataset are freely available at: https://github.com/austinatose/3DICE.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Drug Discovery: Overview
Quantitative Aspects of Drug-Receptor Interaction
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...